VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.
Saved in:
| Title: | VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy. |
|---|---|
| Authors: | Onions KL; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Gamez M; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Buckner NR; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Baker SL; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Betteridge KB; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Desideri S; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Dallyn BP; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Ramnath RD; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Neal CR; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Farmer LK; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Mathieson PW; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Gnudi L; School of Cardiovascular Medicine and Science, British Heart Foundation Centre of Excellence, King's College London, London, U.K., Alitalo K; Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Bates DO; Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, U.K., Salmon AHJ; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Welsh GI; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Satchell SC; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K., Foster RR; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K. becky.foster@bristol.ac.uk. |
| Source: | Diabetes [Diabetes] 2019 Jan; Vol. 68 (1), pp. 172-187. Date of Electronic Publication: 2018 Nov 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30389746 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Onions+KL%22">Onions KL</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Gamez+M%22">Gamez M</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Buckner+NR%22">Buckner NR</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Baker+SL%22">Baker SL</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Betteridge+KB%22">Betteridge KB</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Desideri+S%22">Desideri S</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Dallyn+BP%22">Dallyn BP</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Ramnath+RD%22">Ramnath RD</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Neal+CR%22">Neal CR</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Farmer+LK%22">Farmer LK</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Mathieson+PW%22">Mathieson PW</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Gnudi+L%22">Gnudi L</searchLink>; School of Cardiovascular Medicine and Science, British Heart Foundation Centre of Excellence, King's College London, London, U.K.<br /><searchLink fieldCode="AU" term="%22Alitalo+K%22">Alitalo K</searchLink>; Wihuri Research Institute and Translational Cancer Biology Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Bates+DO%22">Bates DO</searchLink>; Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham, U.K.<br /><searchLink fieldCode="AU" term="%22Salmon+AHJ%22">Salmon AHJ</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Welsh+GI%22">Welsh GI</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Satchell+SC%22">Satchell SC</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K.<br /><searchLink fieldCode="AU" term="%22Foster+RR%22">Foster RR</searchLink>; Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, U.K. becky.foster@bristol.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372763%22">Diabetes</searchLink> [Diabetes] 2019 Jan; Vol. 68 (1), pp. 172-187. <i>Date of Electronic Publication: </i>2018 Nov 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372763 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1939-327X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200121797%22">00121797 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30389746 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2337/db18-0045 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 172 Titles: – TitleFull: VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Onions KL – PersonEntity: Name: NameFull: Gamez M – PersonEntity: Name: NameFull: Buckner NR – PersonEntity: Name: NameFull: Baker SL – PersonEntity: Name: NameFull: Betteridge KB – PersonEntity: Name: NameFull: Desideri S – PersonEntity: Name: NameFull: Dallyn BP – PersonEntity: Name: NameFull: Ramnath RD – PersonEntity: Name: NameFull: Neal CR – PersonEntity: Name: NameFull: Farmer LK – PersonEntity: Name: NameFull: Mathieson PW – PersonEntity: Name: NameFull: Gnudi L – PersonEntity: Name: NameFull: Alitalo K – PersonEntity: Name: NameFull: Bates DO – PersonEntity: Name: NameFull: Salmon AHJ – PersonEntity: Name: NameFull: Welsh GI – PersonEntity: Name: NameFull: Satchell SC – PersonEntity: Name: NameFull: Foster RR IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2019 Jan Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1939-327X Numbering: – Type: volume Value: 68 – Type: issue Value: 1 Titles: – TitleFull: Diabetes Type: main |
| ResultId | 1 |